|
22
<br />naltrexone' oxycodone' oxymorphone, tapentadol, tramadol, opium, heroin,carfentanil, any vafiantof ihese substances, or any similar substance. ,,product,, alsoincludes any natur3l, synthetic, r.rlryntt .tic or cherni.ut .u* materials, startingmaterials, finished active pharmaceutical ingredie;;r;*g substances, and anyrelated intermediate products u..o o. .rruted in the runuFu"tu.ing process foi any ofthe substances described in the preceding sentence.
<br />--'--^*
<br />"Released claims" means any and all claims that directly or indirectly are based on,arise out of, or in any way reiate to or concern the covered conduct occurring priorto the Effective Date' wiihout-limiting theforegoing, in.i"u..a claims,, incl-ude anyclaims that have been asserted againsithe Rele"asedl";irl;; by the State or any of itsLitigating subdivisions in.any f.i..ui, state or local action or proceeding (whetherjudicial, arbitrar, or,administrative) iased o_n, arising ;;;""f
<br />". relating to, in whole orin paft, the covered, conduct, o. unv .r.r, craims trrii"""ro oe or courd have beenasserted now or in the future in those actions or in any
<br />"o.iu.uur. action orproceeding brought !v the state, any orits suuui"i.i,i"r,
<br />"J"ny Rereasors (whetheror not such state, subdivision, or Rereasor has broughiluJ action or proceeding),provided the covered_t_11ol"i,q"cu., frio. to the EFfectiu. out.. Released claimsalso include ail craims asserted in any p.o_ceeding to be dismissed pursuant to theAgreement, whether or not such craims rerate to 6ou"r"i conduct, provided thecovered conduct occurs prior to the Effectiv" out.. ir.,. iJni., intend that"Released craims" be intirpret"o u.ouJry. rni, ag.".r"niao., not rerease craimsby private individuals. It isihe int"nioiitr. parueJtrraiCi"i', by private individuarsbe treated in accordance with uppri.uul. law. ReleaseJc-ruim, is also used herein todesqibe claims brought uv u suuaiuirlon or other non-party Subdivision after theEffective Date that would ituu" b".n n.i.u..o cruim, iitrr"y rruo been brough tby aReleasor against a Released Entity.
<br />"Released Entities" T:3n: Janssen and (r) ail of Janssen,s past and present direct orindirect parents, subsidiaries, divisioni |r.d"...ro.r, .u""""rrl.s, assigns, includingNoramco, Inc. and Tasmanian artaioiis"pry. LTD.; (2) thepast and present director indirect subsidiaries, divisions, unJ;oint ventures,-of uny ortn. foregoing; (3) ailof Janssen's insurers (solely in their roie as insurers with respect to the Releasedclaims); (4) all of Janssen's, o. oru'y
<br />"ntity describeo in *[.r"tion (r), past andpresent joint ventures; and(5) the respeciive.past ""J;;;;;1ffi...r, directors,members, sharehorders (sorery in their capacityas sharehoiders orthe foregoingentities), partners, trustees, agents, and emproy.., orunv oiire foregoing (foractions that occurred during una ..rut.a L u.,"i. r"ort ro'., o,
<br />"rprovment with,Janssen). Any person or .niity described in subsections (3)-(5) shail be a RereasedEntity solely in the capacity describeo ln ,r.r., crause ""i ,rr"rinot be a RereasedEntity with respect to its conduct in un/ oitr., .upu.itv. ro. il" uvoioance of doubt,the entities listed in Exhibit o u.. noi-il.Lu."d Entities; and provided further thatany joint venture paftner of Janssen o.jun.r.n'. subsidiary iJnot u Rereased Entityunless it falls within subsections 1ry-1sj"i""e. A rist of Janssen,s presentsubsidiaries and affiriates is attached ur e*niui, G. Janssen,s predecessor entitiesinclude but are not Iimited to tnos" "niii* rirr.o on Exhibii,i. por the avoidance of
<br />23
<br />4
|